Provided by Tiger Trade Technology Pte. Ltd.

Merck

145.17
+0.46000.32%
Volume:2.56M
Turnover:369.88M
Market Cap:358.16B
PE:114.05
High:145.89
Open:145.77
Low:143.82
Close:144.71
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:0.72
T/O Rate:0.10%
Dividend:3.36
Dividend Rate:2.31%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.54
PE(LYR):19.94

Loading ...

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Reuters
·
Jul 24

Merck: Voluntary Licensing Agreements for Alimatravir Cover 129 Countries

THOMSON REUTERS
·
Jul 24

Merck: Plans Initial Alimatravir Supply Pending Regulatory Approval, Generic Manufacturing Ramp-up in Licensed Territories

THOMSON REUTERS
·
Jul 24

Merck: Announces Initial Access Plans for Alimatravir in Low- and Middle Income Countries for Prevention of Hiv-1

THOMSON REUTERS
·
Jul 24

Merck: in Active Discussions with Fiocruz on Alimatravir Availability in Latin America & Brazil

THOMSON REUTERS
·
Jul 24

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

TIPRANKS
·
Jul 24

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers

MT Newswires Live
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Trade Options When Others are Fearful

Dow Jones
·
Jul 22

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Reuters
·
Jul 22

Merck Posts Press Release on Once-weekly Oral HIV Regimen Trial Results

Reuters
·
Jul 21

Phanes Therapeutics: to Evaluate Spevatamig in Combination with Keytruda & Chemotherapy for Treatment of Biliary Tract Cancer

THOMSON REUTERS
·
Jul 21

Phanes Therapeutics: Expansion of Clinical Trial Collaboration and Supply Agreement with Merck

THOMSON REUTERS
·
Jul 21

Stocks Need Some Tech Magic to Kickstart Market Rally

Dow Jones
·
Jul 20

Palantir Stock Price Still Misses Its Cash Flow Strength

Simply Wall St.
·
Jul 20

UBS Remains a Buy on Merck KGaA (0O14)

TIPRANKS
·
Jul 20

Personalis Has Already Doubled—Is Merck About To Trigger Another Surge?

Smartkarma
·
Jul 20

What Comes After Merck's Keytruda? the Race for the Next Standard Cancer Treatment.

Dow Jones
·
Jul 20

Merck Animal Health Division's Inactivated Intradermal Immunization Vaccine for Porcine Mycoplasma Pneumonia Approved in China - Company Notice

THOMSON REUTERS
·
Jul 20